abs335.txt	widespread	resistance	to	antimicrobial	and	cancer	therapeutics	is	evolving	inevery	country	worldwide	and	has	a	direct	impact	on	global	health		agriculture	andthe	economy		the	specificity	and	selectivity	of	bioactive	peptide	naturalproducts	present	a	possible	stopgap	measure	to	address	the	ongoing	deficit	of	newtherapeutic	compounds		pepsavi-ms	(statistically-guided	bioactive	peptidesprioritized	via	mass	spectrometry)	is	an	adaptable	method	for	the	analysis	ofnatural	product	libraries	to	rapidly	identify	bioactive	peptides		this	pipelinewas	validated	via	screening	of	the	cyclotide-rich	botanical	species	viola	odorataand	identification	of	the	known	antimicrobial	and	anticancer	cyclotidecycloviolacin	o2		herein	we	present	and	validate	novel	bioactivities	of	theanthelmintic	v		odorata	cyclotide		cycloviolacin	o8	(cyo8)		including	micromolaranticancer	activity	against	pc-3	prostate		mda-mb-231	breast		and	ovcar-3	ovariancancer	cell	lines	and	antifungal	activity	against	the	agricultural	pathogenfusarium	graminearum		a	reduction/alkylation	strategy	in	tandem	with	pepsavi-msanalysis	also	revealed	several	previously	uncharacterized	putatively	bioactivecyclotides		downstream	implementation	of	ultraviolet	photodissociation	(uvpd)tandem	mass	spectrometry	is	demonstrated	for	cyo8	as	a	method	to	addresstraditionally	difficult-to-sequence	cyclotide	species		this	work	emphasizes	thetherapeutic	and	agricultural	potential	of	natural	product	bioactive	peptides	andthe	necessity	of	developing	robust	analytical	tools	to	deconvolute	nature'scomplexity	
